Lv1
48 积分 2024-04-09 加入
Neoadjuvant therapy for oesophageal cancer: refining the armamentarium
6天前
已完结
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
10天前
已完结
Targeting HER2-positive breast cancer: advances and future directions
10天前
已完结
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial
12天前
已完结
SOX4 promotes triple-negative breast cancer progression by promoting SRPX2 transcription to regulate AKR1C1
19天前
已完结
Osimertinib combined with anlotinib as first-line treatment in advanced or metastatic NSCLC patients with EGFR mutation: a prospective, single arm, exploratory study
21天前
已完结
Characteristics and Survival Outcomes of Solitary Plasmacytomas: A 30‐Year Experience of the Greek Myeloma Study Group on 175 Patients
26天前
已完结
Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial
1个月前
已完结
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
1个月前
已完结
Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial
1个月前
已完结
皖公网安备34019202002308
